Hardev Pandha Selected Research

Hardev Pandha Research Topics

Disease

66	Neoplasms (Cancer) 01/2024 - 01/2004
33	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 01/2004
19	Melanoma (Melanoma, Malignant) 01/2022 - 12/2004
8	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 06/2013
6	Infections 01/2021 - 12/2008
5	Vesicular Stomatitis 01/2021 - 03/2012
5	Non-Muscle Invasive Bladder Neoplasms 01/2020 - 06/2013
4	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 03/2013
4	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2004
4	Renal Cell Carcinoma (Grawitz Tumor) 06/2016 - 11/2006
3	Disease Progression 12/2023 - 06/2005
3	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 05/2013
3	Experimental Melanoma 05/2015 - 10/2014
2	Necrosis 01/2022 - 10/2009
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2021
2	Brain Neoplasms (Brain Tumor) 01/2018 - 12/2004
2	Glioma (Gliomas) 01/2018 - 02/2015
2	Genetic Risk Score 01/2017 - 01/2016
2	Herpes Simplex 01/2015 - 06/2005
1	Vaccinia 05/2024
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2020
1	Adenocarcinoma 11/2020
1	Microsatellite Instability 01/2020

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2007
17	AntigensIBA 01/2024 - 01/2004
11	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2012
10	CytokinesIBA 01/2022 - 06/2005
9	VaccinesIBA 05/2024 - 01/2004
7	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2018
6	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 12/2005
5	talimogene laherparepvecIBA 01/2020 - 08/2013
5	Transcription Factors (Transcription Factor)IBA 10/2018 - 03/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 05/2010
4	LigandsIBA 08/2021 - 10/2009
4	Neutralizing AntibodiesIBA 01/2021 - 01/2008
4	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 06/2005
3	LipidsIBA 12/2023 - 01/2016
3	RNA (Ribonucleic Acid)IBA 12/2023 - 10/2019
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2023 - 06/2018
3	Antiviral Agents (Antivirals)IBA 01/2021 - 06/2012
3	EpitopesIBA 01/2020 - 11/2014
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019 - 02/2014
3	Hormones (Hormone)IBA 01/2016 - 06/2005
3	Complementary DNA (cDNA)IBA 01/2016 - 03/2012
3	ProdrugsIBA 02/2015 - 06/2005
3	Cancer VaccinesIBA 03/2013 - 06/2005
2	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 08/2021
2	Programmed Cell Death 1 ReceptorIBA 03/2021 - 01/2018
2	Peptides (Polypeptides)IBA 01/2021 - 10/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2020
2	Tumor Biomarkers (Tumor Markers)IBA 11/2020 - 03/2013
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2020 - 06/2018
2	PlatinumIBA 10/2018 - 10/2016
2	InterferonsIBA 01/2018 - 02/2011
2	Oxidoreductases (Dehydrogenase)IBA 01/2017 - 01/2016
2	PLX 4720IBA 05/2015 - 05/2015
2	Conditioned Culture MediaIBA 02/2015 - 02/2011
2	Thymidine KinaseIBA 02/2015 - 06/2005
2	EnzymesIBA 02/2015 - 01/2015
2	Ganciclovir (Cytovene)FDA LinkGeneric 02/2015 - 06/2005
1	ProteomeIBA 12/2023
1	Oleic Acid (Oleate)IBA 12/2023
1	Phosphotransferases (Kinase)IBA 12/2023
1	CDX2 Transcription FactorIBA 11/2023
1	Calcibiotic Root Canal SealerIBA 11/2023
1	ORALIT (ORS)IBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 04/2021
1	Member 14 Tumor Necrosis Factor ReceptorsIBA 03/2021
1	Adenosine (Adenocard)FDA LinkGeneric 03/2021
1	Interferon Type IIBA 03/2021
1	Long Noncoding RNAIBA 01/2021
1	APOBEC-1 DeaminaseIBA 01/2021
1	CytosineIBA 01/2021
1	MutagensIBA 01/2021
1	Viral RNAIBA 01/2021
1	Interferon-betaIBA 01/2021
1	Circular RNAIBA 11/2020
1	Competitive Endogenous RNAIBA 11/2020
1	AndrogensIBA 02/2020
1	Cytidine DeaminaseIBA 01/2020
1	avelumabIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020

Therapy/Procedure

33	Therapeutics 01/2024 - 06/2005
23	Immunotherapy 12/2023 - 04/2005
11	Drug Therapy (Chemotherapy) 01/2021 - 12/2005
9	Oncolytic Virotherapy 01/2022 - 05/2010
3	Castration 01/2023 - 03/2013
3	Intravenous Infusions 01/2022 - 01/2018
3	Radiotherapy 11/2015 - 07/2012
2	Biological Therapy 01/2020 - 06/2018
2	Intravenous Administration 01/2018 - 11/2015
2	Prostatectomy (Retropubic Prostatectomy) 10/2017 - 09/2012
2	Cryotherapy (Therapy, Cold) 12/2010 - 10/2009
1	Adjuvant Chemotherapy 01/2020